Pargol Samani

Pargol Samani practices at Pargol Samani MD Inc in Oceanside, California.

Pargol Samani's NPI, 1881982486, was assigned on July 16, 2011. Pargol Samani graduated from Isfahan University of Medical Sciences in 2008. Pargol Samani's California license number on file is A141390.

Pargol Samani's primary practice is Pargol Samani MD Inc, at 3231 Waring Ct, Oceanside, CA 92056 in San Diego County. The practice phone is (619) 703-7220.

Pargol Samani's primary practice is Pargol Samani MD Inc in Oceanside, California. Pargol Samani is also affiliated with Sharp Tri-City Medical Center. The medical group on file is San Diego County Cardiology. Dmand AI also links Pargol Samani to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Pargol Samani practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Pargol Samani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Pargol Samani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Pargol Samani's licenses on file in 3 states: California, Ohio and Michigan.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension and coronary artery disease among the conditions Pargol Samani treats.

CMS data shows 8,545 Medicare services from Pargol Samani across 31 procedure codes in 2024, for 898 Medicare patients. Medicare paid $1,058,208 for them.

CMS counts 898 Medicare patients who saw Pargol Samani in 2024. The largest group is 65 to 74, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Pargol Samani's median patient age at 70, with 58% women.

In 2024, Pargol Samani wrote 5,506 Medicare Part D claims for 770 patients. 83% of them were for generic drugs. CMS names the drug for 5,235 of them, across 66 drugs with 11 or more claims each, at $1,024,116 in total drug cost. In 2023, CMS named 4,907 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Pargol Samani for performance year 2024, reported individually. Pargol Samani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Pargol Samani as offering telehealth.

CMS Open Payments shows 523 general payments to Pargol Samani from 50 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $2,786.

Pargol Samani graduated from Isfahan University of Medical Sciences in 2008. Pargol Samani is a member of ACC, AMA and ASNC.

Pargol Samani is in network with 7 carriers, including Aetna, Humana and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.